NCT00003626View on ClinicalTrials.gov

Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 1998

Primary Completion Date

December 31, 1999

Study Completion Date

May 31, 2000

Conditions
Prostate Cancer
Interventions
DRUG

dolastatin 10

Trial Locations (3)

19111

Fox Chase Cancer Center, Philadelphia

48201

Barbara Ann Karmanos Cancer Institute, Detroit

80262

University of Colorado Cancer Center, Denver

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Barbara Ann Karmanos Cancer Institute

OTHER

NCT00003626 - Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy | Biotech Hunter | Biotech Hunter